Efficacy of EDTA-tris-lysozyme lavage in the treatment of experimentally in induced Pseudomonas aeruginosa cystitis in the dog
Wooley, R.E.; Schall, W.D.; Eagon, R.G.; Scott, T.A.
American Journal of Veterinary Research 35(1): 27-29
1974
ISSN/ISBN: 0002-9645 PMID: 4203507 Document Number: 74606
Lavage with a solution composed of ethylenediamine-tetraacetate, lysozyme, and tris (hydroxymethyl) aminomethane (tris) buffer was effective in the treatment of experimentally induced P. aeruginosa cystitis in dogs. This treatment would be effective for the treatment of cystitis caused by other gram-negative bacteria and also antibiotic resistant organisms.
Document emailed within 1 workday
Related Documents
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18Rajasekhar, M.; Keshavamurthy, B.S. 1976: Acute cystitis due to Pseudomonas aeruginosa in a race-horse Veterinary Record 99(11): 214-215
Takahashi, T.; Suga, M.; Sato, K.; Okamoto, R.; Ichiyasu, H.; Matsukawa, A.; Okawara, S.; Yoshinaga, H.; Ando, M. 2000: Efficacy of erythromycin (EM) on a rabbit model of Pseudomonas aeruginosa-induced chronic bronchiolitis--its action on apoptosis Japanese Journal of Antibiotics 53 Suppl A: 89-91
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Stakislavskiĭ, E.S.; Kolker, I.I. 1978: Immunological study of cellular components of Pseudomonas aeruginosa. IV. Fractionation of Pseudomonas aeruginosa mucus by diafiltration and biological properties of isolated fractions Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 50-55
Ritzerfeld, W. 1987: Efficacy of pefloxacin in experimental Pseudomonas aeruginosa pyelonephritis Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 184-185
Yancey, R.J.; Evans, R.A.; Kratzer, D.D.; Paulissen, J.B.; Carmer, S.G. 1990: Efficacy of ceftiofur hydrochloride for treatment of experimentally induced colibacillosis in neonatal swine American Journal of Veterinary Research 51(3): 349-353
Mayeda, A.; Krainer, A.R. 1991: Long-term storage of concentrated tris-borate-EDTA electrophoresis buffers without precipitation Biotechniques 10(2): 182
Samsygin, S.A.; Ovchinnikova, E.A.; Krasovskaia, T.V.; Dolgina, E.N.; Ekk, N.D. 1992: The efficacy of specific plasma in the therapy of newborn infants with a Pseudomonas aeruginosa surgical infection Khirurgiia 1992(11-12): 61-65
Illarionov, E.F.; Samoĭlov, P.M.; Eroshin, V.K. 1977: Alkane-induced protein biosynthesis in Pseudomonas aeruginosa Mikrobiologiia 46(6): 1027-1033
Michałkiewicz, J.; Patzer, J.; Dzierzanowska, D.; Stachowski, J.; Madaliński, K. 1989: Effect of Pseudomonas aeruginosa exotoxin a on PHA-induced lymphocyte proliferation Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 353-363
Mikasa, K.; Sawaki, M.; Konishi, M.; Narita, N. 1990: Clinical efficacy of imipenem/cilastatin sodium in patients with respiratory tract infections caused by Pseudomonas aeruginosa Japanese Journal of Antibiotics 43(1): 9-13
Carlone, N.; Ferrero, M.; Cuffini, A.; Cavallo, G. 1987: Ultrastructural modifications induced by imipenem and their implications in the pathogenicity of Pseudomonas aeruginosa Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 73-74
Schreiber, J.R.; Patawaran, M.; Tosi, M.; Lennon, J.; Pier, G.B. 1990: Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa Journal of Immunology 144(3): 1023-1029
Furukawa, T.; Uji, T.; Miyake, Y.; Hyodo, A.; Deguchi, K. 1993: Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice Japanese Journal of Antibiotics 46(6): 472-481
Nomiya, B.; Kawaharajo, K.; Watanabe, T.; Tamura, S. 1972: Pseudomonas aeruginosa. I. Isolation of P. aeruginosa in nature and animals, with special reference to mice and guinea pigs Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 27(5): 641-648
Lagowska-Złotorzycka, M.; Czarny, A.; Mulczyk, M. 1987: Effect of slime extract from Pseudomonas aeruginosa on cell mediated immunity induced in mice by Salmonella typhimurium Archivum Immunologiae et Therapiae Experimentalis 35(3): 277-281
Dilmen, U.; Kanra, G.; Yilgör, E.; Ozsoylu, S. 1983: Netilmicin in the treatment of Pseudomonas aeruginosa meningitis Turkish Journal of Pediatrics 25(1): 59-62
Treshchanina, N.A.; Nesmeianova, M.A.; Zhdan-Pushkina, S.M. 1981: Exogenous orthophosphate regulation of the phosphohydrolase activities of Pseudomonas aeruginosa and Pseudomonas maltophilia Mikrobiologiia 50(6): 996-1001
Cisterna Cancer, R. 1998: General characteristics of Pseudomonas and other related bacteria. Pathogenic ability of Pseudomonas aeruginosa Revista Clinica Espanola 198(Suppl 2): 3-9